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In contrast with most Epstein –Barr virus (EBV)-infected healthy carriers, nasopharyngeal carcinoma patients frequently
have increased serum levels of antibodies directed against EBV-DNase. These antibodies are potentially interesting serologi-
cal markers for the diagnosis and the follow-up of nasopharyngeal carcinoma (NPC). In this context, it is important to
determine whether malignant EBV-infected cells are the source of significant amounts of EBV-DNase contributing to antigenic
stimulation. Therefore EBV-DNase expression has been investigated in several NPC specimens. A significant expression
of this viral enzyme was demonstrated in both fresh biopsies and transplanted tumor lines. The DNase isolated from tumor
has a molecular weight varying between 52 and 60 kDa and its activity eluted from a single-stranded DNA affinity column
was specifically inhibited by both NPC sera and the rabbit polyclonal antibody against EBV-DNase. The enzyme activity
was functional in the presence of 300 mM KCl, with which cellular DNases are completely inhibited. The DNase was mainly
localized in epithelial tumor cells of both NPC biopsies and nude mice-derived NPC cells. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1984; Chen et al., 1985), thymidine kinase (De
Turenne-Tessier et al., 1989; Littler and Arrand, 1988),
The contribution of Epstein– Barr virus (EBV) to the
and DNA polymerase (Liu et al., 1989; Lin et al., 1995).
etiology of nasopharyngeal carcinoma is attested by sev-
The DNase-neutralizing antibodies were found to de-
eral facts: the constant presence of the EBV genome in
crease during prolonged remission periods (Chen et al.,
all malignant cells (Zur Hauzen et al., 1970; Klein, 1973),
1987). An increase in anti-DNase titers is associated with
the expression of several viral proteins with known onco-
a higher risk of local recurrence or metastatic relapse
genic activity (Wang et al., 1985; Wilson and Levine,
(Hsu et al., 1986). Despite the absence of viral particles,
1992), and the expression of serological modifications several authors have detected early viral proteins, ZE-
(de The´ et al., 1987; Ooka et al., 1991). Several viral tran-
BRA, EA-D, and EA-R, in malignant cell foci of NPC biop-
scripts are consistently found in nasopharyngeal carci-
sies, both by immunoblot or immunohistochemistry (Luka
noma (NPC): the noncoding EBERs (Wu et al., 1991), mes-
et al., 1988; Lung et al., 1989; Cochet et al., 1993; Sam et
senger RNAs coding for EBNA1, LMP1, LMP2A, and
al., 1993). Transcripts containing the EBV-DNase coding
LMP2B, and rightward transcripts from the BamHI-A re-
sequence have been reported in a cDNA library derived
gion (Hitt et al., 1989; Gilligan et al., 1991; Chen et al.,
from the transplantable C15 NPC (Hitt et al., 1989). In
1992; Brooks et al., 1992; Busson et al., 1992). At least two
addition, the EBV-DNase has been detected by immuno-
latent viral proteins are consistently expressed: EBNA1 in
histochemistry in some oral hairy leucoplakia biopsies
100% and LMP1 in about 60% of NPC tumors (Fahraeus
(Baylis et al., 1991), thus inviting further investigations of
et al., 1988; Young et al., 1988).
this enzyme in other types of EBV-infected epithelial
Paradoxically while no viral particles are detected in
cells. For these reasons, the expression of the EBV-
tumor tissue in situ, the serological profile of NPC pa- DNase has been analyzed in NPC specimens in terms
tients is characterized by high titers of anti-EA and anti-
of transcription, protein expression, and biological activ-
VCA antibodies as well as anti-EBNA antibodies (de The´
ity. Our study shows that a biologically active EBV-DNase
et al., 1987; Ooka et al., 1991). In addition, sera from
is consistently expressed in a fraction of NPC tumor cells.
NPC patients had the capacity to neutralize the activity
of several EBV enzymes: DNase (Cheng et al., 1980; Ooka
MATERIALS AND METHODS
Clinical samples1 To whom correspondence and reprint requests should be ad-
dressed at Laboratoire de Virologie Mole´culaire, IVMC, CNRS, Faculte´
Eight NPC biopsies were collected at Mustapha Hos-de Me´decine Alexis Carrel, Rue G. Paradin, 69372 Lyon, Cedex 08,
pital (Algeria). Clinical staging was variable, ranging fromFrance. Fax: 78-74-96-68. E-mail: Internet, ooka1@cimacpcu.univ-ly
on1.fr. T1 to T4. All specimens were histologically diagnosed
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as NPC of the undifferentiated type (WHO III). Biopsies incubated with antibody overnight at 47. DNase was de-
tected by the rabbit polyclonal antibody against EBV-from the primary site (0.1– 0.5 g) were snap-frozen in
liquid nitrogen immediately after surgical removal and DNase (Stolzenberg and Ooka, 1990) with a 1:50,000 dilu-
tion. In a parallel way, preimmune rabbit sera were usedthen stored at 0807C. Each sample was cut into two
pieces; one-half was used for RNA extraction and the with the same dilution as the negative control. After
washing, the filters were incubated for 1 hr at room tem-second half was divided for DNA and protein extraction.
We also used C15, C17, and C18 propagated in nude perature with peroxidase-labeled anti-rabbit antibodies.
The antigen– antibody complexes were then visualizedmice (Busson et al., 1988).
All biopsies used here contained the EBV genome as by using an enhanced chemiluminescence system (ECL,
Amersham) as instructed by the manufacturer.shown by PCR amplification of both BGLF5 and BARF1
ORFs encoding EBV-DNase (Zhang et al., 1987) and p33
In situ hybridizationtransforming early protein (Wei and Ooka, 1989), respec-
tively. EBV antibody titers against IgG-EA and IgA-EA
The presence of EBV in tumor cells was investigated
from NPC patients tested (from whom the tumors were
in paraffin wax-embedded NPC biopsies by in situ hybrid-
isolated) were as follows: IgG-EA titer  1: 40– 640 and
ization using digoxigenin-labeled EBER-1 riboprobe. As
IgA-EA titer  1: 10– 40. These sera contained also the a control, digoxigenin-labeled antisense riboprobe was
antibody against EBV-DNase. used. The method has been described previously (Wu et
al., 1991). Briefly, sections were deparaffinated with xy-Cell culture
lene and rehydrated through a series of ethanol and PBS.
The EBV-carrying P3HR-1 cell line and EBV-negative Incubated samples were then treated sequentially with
Louckes and BJAB cell lines were grown as previously 0.2 N HCl for 12 min at room temperature and 0.25 mg/
described by Ooka et al. (1983). For lytic cycle induction, ml of proteinase K (Boehringer) for 10 min at 377. The
P3HR-1 cells were treated with 50 ng/ml of 13-O-tetrade- slides were then dehydrated through graded ethanols
canoyl-phorbol-esther (TPA) and 2 mM sodium butyrate and prehybridized in a solution containing 50% for-
(SB) for 72 hr. EBV-negative human epithelial RHEK-1 (a mamide, X4 saline sodium citrate (SSC), 5% dextran sul-
gift from J. Rhim, National Cancer Institute) (Rhim, 1989), fate, 11 Denhardt’s solution, 100 mg/ml denaturated
HaCaT (a gift from Dr. Fusenig, Institut fu¨r Biochemie, salmon sperm DNA for 1 hr at room temperature. Hybrid-
Heiderberg, Germany) (Boukamp et al., 1988), and BEC ization was carried out overnight at 427 in the same mix-
(SCC12F transfected with pZip vector, a gift from Dr. A. ture containing the labeled probe at a final concentration
Rickinson, Birmingham), cell lines were maintained in of 1 ng/ml. After hybridization, slides were submerged in
Dulbecco’s modified Eagle’s medium supplemented with 41 SSC and the coverslips were removed. The tissue
10% fetal bovine serum. sections were washed in 11 SSC at room temperature
and 0.11 SSC at 427. Detection of EBER-1 was done
Preparation of NPC cell extracts using an avidin– biotin – peroxidase complex as de-
scribed below.NPC biopsies were thawed in lysis buffer A containing
50 mM Tris– HCl (pH 8), 1 mM dithiothreitol (DTT), 10 mM
ImmunohistochemistryKCl, 1 mM PMSF, and 1 mM protease inhibitor cocktail kit
(ICN Biochemicals, CA). Lysates were frozen and thawed Immunohistochemistry was performed on paraffin-em-
three times, sonicated three times for 30 sec with a Bran- bedded NPC biopsies and c18 tumor using as primary
son B-15 sonicator, and then centrifuged at 105,000 g for antibodies the rabbit polyclonal EBV DNase serum (at
60 min in a Beckman 50 TI rotor. The supernatant was dilution, 1:500); a mouse monoclonal antibody, L26, di-
frozen at 0807 until required. rected against the human B cell CD20 antigen (1:100)
(Dako); and a polyclonal rabbit antiserum directed
Immunoblotting
against human T cell CD3 antigen (1:100) (Dako). Immu-
nohistochemical detection was performed by the avidin–Thirty to 50 mg of proteins quantitated by a Bio-Rad
protein assay (Bio-Rad Laboratories, Inc.) were diluted biotin – peroxidase complex (ABC) method using the
StreptABComplex/HRP Duet, mouse/rabbit kit (Dako).with one volume of gel sample buffer (0.05% bromophe-
nol blue, 2% SDS, 5% 2-b-mercaptoethanol, 10% glycerol, Briefly, deparaffinized sections were pretreated with 30%
H2O2 for 20 min, washed, and blocked with a nonimmune50 mM Tris – HCl, pH 6.8) and boiled. Protein samples
were separated on polyacrylamide gel and blotted onto goat serum for 25 min. Slides were then incubated with
diluted primary antibodies for 25 min, washed threereinforced nitrocellulose as previously described (De-
caussin et al., 1995). Nonspecific protein-binding sites times, and incubated with biotinylated secondary anti-
bodies for 30 min, followed by incubation with avidin andon blotted filters were blocked by incubation overnight
in phosphate-buffered saline (PBS) with 0.1% Tween 20 biotinylated horseradish peroxidase complex. All incuba-
tions were done at room temperature. Revelation wasand 5% dried skim milk. The filters were subsequently
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performed using the 3*-3-diaminobenzidine (DAB, Dako) matic reaction. EBV-DNase activity was then determined
as described above at various times of incubation (15,plus five drops of 3% H2O2. The slides were counter-
stained with hematoxyline, dehydrated, coverslipped, 30, 60, and 120 min).
and examined under 40X magnification. Positive staining
Northern blotwas visible as a brownish color. Negative controls were
carried out as described above. RNA was extracted using an RNA isolation kit (Stra-
tagene). Polyadenylated RNA (poly(A)/) was separatedSingle-stranded DNA cellulose affinity column
from the total cellular RNA fraction by the streptavidin
Two NPC biopsy lysates (7-T3 and 3-T1) were used for magnetic particle method according to the manufactur-
DNase purification on a single-stranded DNA cellulose er’s protocol (Poly(A)Tract mRNA Isolation System III,
column. EBV-DNase induced in P3HR-1 cells was also Promega). For Northern blot analysis, 5 –10 mg of
purified in parallel. Six hundred micrograms of soluble poly(A)/ RNA was loaded onto a 1% agarose gel con-
protein extracts were applied to 300 ml of single-stranded taining formaldehyde and separated by electrophoresis
DNA cellulose (Sigma) equilibrated in buffer A. Non- (Wei et al., 1994). RNA was transferred to Hybond-N
bound material was discarded by centrifugation, and the membrane by capillarly transfer. Radiolabeled DNase ri-
DNase was eluted with serial concentrations of NaCl boprobe was prepared from the cDNA sequence of
increasing from 0.05 to 0.8 M, by the batch system. One- BGLF5 inserted into the pGEM vector (Zhang et al., 1987)
hundred-microliter fractions were collected, to which by SP6 polymerase (Promega). Hybridization was carried
BSA and glycerol were immediately added to final con- out overnight at 607 in a solution containing 50% for-
centrations of 0.1 and 10%, respectively. NaCl concentra- mamide, 0.05 M sodium phosphate (pH 7.2), 2.51 Den-
tion was measured by refractometry. The fractions were hardt’s solution, 51 SSC, 100 mg/ml salmon sperm DNA,
then stored at 01607. and 200 mg/ml yeast RNA and washed twice with 21
SSC containing 0.1% SDS at 607 for 30 min and twice
DNase activity assay with 0.11 SSC, 0.1% SDS at 607 for 20 min.
EBV-specific DNase activity was measured by using
Reverse transcriptase – polymerase chain reactionradioactive substrate as previously described (Ooka et
(RT-PCR)al., 1984). Briefly, in a 60-ml final volume, 20ml of superna-
tant (containing 100 mg of protein) or eluted fractions Five micrograms of total RNA was used for first-strand
from DNA column was incubated for 1 hr at 377 with 1 cDNA synthesis in a 40-ml reaction volume using oli-
mg of 32P-labeled calf thymus DNA corresponding to go(dT)15 as primer. Reverse transcription was done with
20,000 cpm prepared with a random primer DNA labeling Superscript reverse transcriptase according to the in-
kit (Stratagene) in 50 mM Tris – HCl (pH 8), 1 mM DTT, structions of the manufacturer (GIBCO, BRL). Newly syn-
and 3 mM MgCl2 . The enzyme reactions were performed thesized cDNA was aliquoted and stored at 0207C. PCR
in the presence of 10 or 300 mM KCl. At 10 mM, both amplification was performed using 0.1 volume of the first-
viral and cellular DNase activities were functional. At 300 strand reaction mixture, 0.8 U of Taq polymerase (Ampli-
mM, cellular DNase activity is totally inhibited, while EBV- Taq, Perkin – Elmer), 3 mM MgCl2 , and 2.5 mmol of each
specific DNase activity is still functional (Ooka et al., primer, 5*-primer, GGGAATTCTTGGTCCAGATGGCCG-
1984). The reaction was stopped by the addition of 20 ACGTG, and 3*-primer, GGGGATCCCATGGCGCGGTGT-
mM EDTA and heated at 657 for 10 min. The amount of CAAAAGT, at positions 122,350 and 120,971, respec-
acid-insoluble material was determined by spotting 25-ml tively, on the BGLF5 sequence, giving 1379 bp of ampli-
samples of reaction mixtures onto Whatman GF/C glass- fied fragment, in a 25-ml reaction mixture containing 50
fiber disks and precipitating with a 10% cold trichloroace- mM of each deoxyribonucleotide triphosphate and a stan-
tic acid solution. DNase activity is expressed as the dard PCR buffer. These primers permit the amplification
amount (in counts per minute) of acid-soluble nucleo- of an entire EBV-DNase sequence of 1.4 kb. For each
tides released after 1 hr of incubation at 377. sample, a control tube without reverse transcriptase was
added (designated RT0). Amplifications were performed
Neutralization of DNase activity
in a DNA thermal cycler (Bio-Rad) as follows: denatur-
ation at 947 for 20 sec, annealing at 557 for 30 sec, andSpecific inhibition of EBV-DNase activity from P3HR-1
cells and two NPC biopsies (3-T1, 7-T3) was tested with extension at 757 for 1 min. Thirty-five cycles were used
for amplification. Aliquots of the PCR mixture were subse-two sera: IgG VCA titer, 1:2560 and IgG EA titer, 1:640,
which are respectively, human serum from an Algerian quently analyzed by electrophoresis through a 1% agar-
ose gel followed by Southern transfer onto Hybond-N/NPC patient and the rabbit polyclonal serum against
EBV-DNase which has been previously mentioned. The nylon membranes (Amersham). Detection of amplified
DNase sequence was achieved by hybridization to a 32P-enzyme was preincubated with an equal volume of each
serum for 20 min at room temperature before the enzy- labeled BGLF5 sequence using a random primer DNA
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FIG. 1. (a) Northern blot analysis of EBV-DNase transcript in primary NPC and transplantable C15 and C18 biopsies. Five micrograms of
polyadenylated RNA was electrophoresed and blotted onto Hybond filter and the filter was hybridized with BGLF5 riboprobe (Zhang et al., 1987).
The amount of poly(A) RNA electrophoresed was determined by GAPDH RNA detection. (b) Identification of DNase transcript by reverse transcriptase –
polymerase chain reaction (RT-PCR). The transcription of BGLF5 ORF encoding EBV-DNase was analyzed on three NPC biopsies and C15 and
C18 nude mice tumors by RT-PCR. Five micrograms of total RNA was used in each reaction. After cDNA synthesis using Superscript reverse
transcriptase, PCR amplification was performed using the primers which amplify the entire DNase sequence of 1.4 kb. Simultaneously, RNA not
treated with reverse transcriptase, designated RT0, was amplified and used as control. 1.4-kb products were transferred onto Hybond-N/ nylon
membrane. The membrane was hybridized with a BGLF5 cDNA sequence used as probe. EBV-negative Louckes B cells were used as negative
control and TPA-SB-treated EBV-carrying P3HR-1 cells as positive control.
labeling kit (Stratagene). The filter was hybridized as pre- like IB4 or Namalwa (data not shown). Positive responses
obtained are probably specific, because RNA withoutviously described (Bouzid et al., 1993).
reverse transcriptase (RT0) was totally negative, indicat-
ing that the positive signal did not come from contami-RESULTS
nated DNA present in the RNA preparation. One of three
Transcription of EBV DNase gene
NPC tumors did not give any signal, probably due to RNA
degradation.Since only small fragments of tumor were available
(because a large part of tumor fragment was used for
immunoblotting, enzyme purification, and enzyme activity Detection of EBV-DNase by immunoblot
assays), only two primary NPC (7-T3, 3-T1) RNAs and
two other transplantable C15 and C18 RNAs were ana- The expression of EBV-DNase was analyzed in seven
NPC biopsies as well as in three transplantable tumorslyzed by Northern blot (Fig. 1a). No significant bands
were revealed from primary and C15 biopsies, while two (C15, C17, and C18) by immunoblotting using the rabbit
polyclonal antibody against EBV-DNase. At first, EBV-transcripts with major 1.8- and a 3.8-kb bands were iden-
tified in the C18 tumor. Their sizes were similar to those DNase expression was analyzed in EBV carrying B95-8
and P3HR-1 cell lines as well as in EBV-negative BJABobtained from P3HR-1 (Zhang et al., 1987). However, it
should be noted that a negative signal obtained from two and Louckes cell lines. Figure 2 (left) shows the immu-
noblot of B-cell extracts incubated with polyclonal EBV-primary NPC could come from the quantity of RNA loaded
onto the gel, in particular for the 7-T3 biopsy (see the DNase antibody. Both TPA-SB-treated P3HR-1 and B95-8
cells expressed 52-kDa EBV-specific DNase, while EBV-intensity of band revealed with GAPDH probe). A slight
positive signal was, however, obtained for C15, 3-T1, and negative BJAB and Louckes cells did not show any posi-
tive signal. The results from NPC biopsies are presented7-T3 after a long exposure.
In order to confirm these results, the RT-PCR method in the right panel of Fig. 2 (IA and IB). All seven biopsies
tested were positive; four of them had a protein of thewas used to analyze the transcription of the DNase gene
on transplantable NPC tumors in athymic nude mice (C15 same molecular weight (52 kDa) as that of the P3HR-1
strain and three others had higher molecular weights ofand C18) and three NPC biopsies (3-T1, 7-T3, 8-T4). As
shown in Fig. 1b, a 1.379-kb band was similarly amplified about 60 kDa for 4-T2 and 53 – 55 kDa for 2-T1 and 3-T1.
A polypeptide of about 53 kDa was revealed in the C18from C15-, C18-, 3-T1-, 7-T3, and TPA-SB-treated P3HR-
1 cDNA. No signal was obtained from RNA from EBV- tumor, but C15 and C17 showed very faint bands of about
52 kDa. In four of seven biopsies (7-T3, 8-T4, 1-T1, andnegative Louckes cells, nor from tightly latent cell lines
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FIG. 2. Immunoblot of DNase from EBV-positive or -negative B cells, NPC biopsies, and nude mice tumors. (Left). EBV-DNase identified in
EBV-carrying B cell lines: TPA-SB-treated P3HR-1 and B95-8 cells. EBV-negative Louckes and BJAB cell lines used as negative controls. (Right).
EBV-DNase from NPC biopsies and three nude mice tumors. Protein extracts prepared from NPC biopsies (4-T2, 7-T3, 5-T2, 8-T4, 1-T1, 3-T1,
and 2-T1) and nude mice tumors (C15, C17, C18) were loaded onto 10% SDS – polyacrylamide gel. After electrophoresis, the proteins were
transferred onto nitrocellulose and the filters were incubated with immune rabbit polyclonal serum (IA and IB) or with preimmune serum (P).
Molecular weights are indicated.
2-T1), several bands were revealed by anti-DNase anti- are summarized in Table 1. The EBV nonproducing Raji
body. In the case of 7-T3, three major bands with ap- line was used as a viral DNase-negative control and
proached molecular weight were constantly detected. TPA-SB-treated P3HR-1 (in which EBV-DNase is in-
Thus DNase MW (molecular weight) varies in NPC from duced) and purified EBV-DNase from recombinant ba-
52 to 60 kDa. Variations in DNase electrophoretic mobil- culovirus were used as positive controls. At 10 mM,
ity and in DNase activity depending on virus strain have all NPC samples showed the DNase activity varying
already been reported after superinfection on Raji cells from 17 to 92% except for the 6-T3 NPC biopsy. At
(Williams et al., 1988). Major polypeptides identified on 300 mM, viral DNase activity was found in all positive
immunoblotting likely correspond to EBV DNAse mole- controls, NPC biopsies, and transplantable NPC tu-
cules, since no significant band was detected in EBV- mors except for 6-T3, while the Raji cell extract had no
negative epithelial cell extracts (BEC, RHEK-1, and Ha- such activity. We noticed that the absence of any en-
CaT), nor in EBV-negative BJAB and Louckes lymphoid zyme activity in 6-T3 is probably due to the loss of
cell extracts. Rabbit preimmune serum did not reveal any enzyme activity during biopsy freezing or enzyme ex-
band in samples tested (Fig. 2, P). traction. Enzyme activity was particularly intense in the
7-T3 NPC biopsy. All transplantable NPC tumors
showed relatively lower activities than fresh NPC biop-DNase activity in NPC biopsies
sies. Since the same concentration of protein was
used for all assays, the percentage of enzyme activityWe asked whether the polypeptide revealed in NPC
is comparable among them. It should be noticed thattumors has EBV-specific DNase activity. Viral enzyme
three of them (3-T1, 4-T2, and 8-T4) had higher activityactivity was searched in NPC biopsies as well as in
at 300 mM than at 10 mM; 7-T3 NPC had about thetransplantable NPC tumors. The EBV-specific DNase
same activity in both concentrations. These high activi-activity was measured for two concentrations of KCl
ties observed at a concentration of 300 mM probably(10 and 300 mM) in NPC extracts. Results obtained
from eight biopsies and three transplantable tumors reflect the high amount of viral enzyme in those tumors.
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TABLE 1
DNase Activity of NPC Biopsies and Nude Mice Tumors
KCl
10 mM 300 mM
Total cpm Remaining DNase Remaining DNase
on filter cpm on filter activity (%) cpm on filter activity (%)
Control cell lines
RAJI 20,000 8,700 56 20,000 0
P3HR-1a 20,000 540 97 8,888 55
EBV DNaseb 20,000 840 95 11,500 42
NPC Biopsies
1-T1 20,000 4,375 77 14,000 30
2-T1 20,000 9,750 51 17,500 12
3-T1 20,000 13,000 34 12,000 40
4-T2 20,000 16,470 17 11,760 41
5-T2 20,000 13,000 34 12,800 35
6-T3 20,000 20,000 0 19,000 0
7-T3 20,000 1,580 92 2,000 90
8-T4 20,000 13,284 33 9,840 51
Nude mice tumors
C15 20,000 6,800 66 16,000 19
C17 20,000 10,000 49 16,000 19
C18 20,000 11,500 43 17,000 15
Note. T, Tumor stage.
a TBA-SB-treated P3HR-1.
b Purified EBV-DNase from Baculo virus system.
The DNase activity was present in NPCs at various The fractions eluted from 0.2 – 0.3 M for P3HR-1 and
3-T1 and 0.8 M for 7-T3 were used as an enzyme sourceclinical stages (T1 to T4).
for neutralization assays. In order to inhibit any contami-
Neutralization assay of DNase activity nating cellular DNase, all enzyme activity assays were
carried out in the presence of 300 mM KCl. NeutralizationTo further confirm that the activity found with 300 mM
kinetics were summarized in Fig. 4. Without sera, 32P-KCl was of viral origin, the neutralization assays were
labeled DNA was gradually degraded with increasingcarried out on NPC tumor extracts using both NPC sera
incubation time reaching a plateau at about 2 hr: maximaland EBV-DNase-specific rabbit antibody. Crude extracts
degradation was 47 and 50% for 3-T1 and 7-T3, respec-prepared from NPC biopsy with buffer A showed a mod-
tively. P3HR-1 viral enzyme degraded about 60% of DNAest 5% inhibition with both antisera (data not shown).
for the same length of incubation. When the enzymesThis low inhibition is possibly due to the presence of
were incubated with NPC serum or the polyclonal rabbitsome impurities in the NPC extract. We therefore partially
serum (anti-DNase), all DNase activities (P3HR-1, NPCpurified the viral enzyme from NPC biopsy and P3HR-1
3-T1, or 7-T3) were inhibited.cells using single-stranded DNA affinity chromatography.
Two NPC biopsies (3-T1 and 7-T3) and P3HR-1 cell ex-
Immunohistochemistry
tracts were subjected to chromatography and elution
with an NaCl gradient. The elution patterns are presented EBV-DNase distribution was investigated on NPC tis-
sue sections. Serial sections from five NPC biopsiesin Fig. 3. DNase activity was measured on each fraction
in the presence of 10 or 300 mM KCl. Most cellular were analyzed for in situ detection of both EBER1 and
EBV-DNase expression. Nonradioactive riboprobe hy-DNase activity was eluted at 0.1– 0.2 M NaCl for 3-T1
and P3HR-1, and viral activity was found at 0.2 – 0.3 M bridization and immunohistochemistry with a specific
polyclonal serum were used for EBER 1 and EBV-DNase,for both P3HR-1 and 3-T1. In the case of 7-T3, the elution
pattern was quite different: at 300 mM KCl a high activity respectively.
Figure 5 displays a typical histological aspect of undif-was observed in all fractions from 0.4 to 0.8 M NaCl.
AID VY 8031 / 6a1b$$$543 07-08-96 10:01:43 vira AP: Virology
70 SBIH-LAMMALI ET AL.
FIG. 3. Histogram showing elution pattern of DNase activity from NPC biopsies (3-T1 and 7-T3) and TPA-SB-treated P3HR-1. Fractions were
eluted at different concentrations of NaCl, and DNase activity was measured in the presence of 10 or 300 mM KCl. 0 mM KCl indicated in the
figure corresponds to 10 mM KCl present in the extraction buffer. The percentage of the total amount of degraded radiolabeled DNA is presented
as DNase activity.
ferentiated NPC. The field is predominantly occupied by consistent with a distribution of the EBV genome re-
stricted to the malignant epithelial cells. EBV-DNase waslarge tumoral cordons; abundant small lymphocytes are
also observed, either in the periphery of tumor cordons detected on sections from two of five NPC biopsies: 3-
T1 and 7-T3. No staining was observed with the rabbit(Fig. 5A) or intermingled with malignant epithelial cells
(Fig. 5B). A significant expression of EBER 1 was ob- preimmune serum (Fig. 5E). Both the control and the
specific sera did not stain normal epithelium adjacent toserved in malignant epithelial cells with high staining
concentrations inside the nucleus or at the nuclear mem- the tumor region (data not shown). Specific DNase stain-
ing was observed in relatively large zones of malignantbrane (Fig. 5D). In some cells, the cytoplasm was also
stained. In contrast, EBER 1 staining was totally absent cells with both nuclear and cytoplasmic distribution. In
the 7-T3 tumor, staining was maximal at the periphery ofin tumor lymphocytes. No staining was obtained with
the anti-sense probe (Fig. 5C). These observations are the nucleus (Fig. 5F). In 3-T1, it was more abundant in
FIG. 4. Neutralization of EBV-DNase activity from NPC biopsies (3-T1 and 7-T3) and P3HR-1 by NPC serum or by immune rabbit polyclonal serum
against EBV-DNase. Enzyme reaction was carried out in the presence or absence of serum. At intervals of 15, 30, 60, and 120 min of incubation
time, an aliquot was removed and spotted onto Whatman GF/C filter. The filters were immersed in cold TCA solution. The amount of acid-insoluble
DNA retained on the filter is presented.
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FIG. 5. Immunohistochemistry of EBV DNase. (A and B) Immunostaining of NPC tumor by immunoperoxidase technique; the presence of infiltrating
T lymphocytes revealed by anti-CD3 (A) and B lymphocytes revealed by anti-CD20 (B) in NPC tumor cells on paraffin section. Fusiform tumor cells
with oval nuclei are arranged in irregular cordons. (C and D) In situ hybridization was carried out with digoxigenin-labeled EBER sense or anti-
sense probe. No positive signal was detected with the sense to anti-sense probe on the paraffin section (C). Positive EBER RNA expression (in
red) was observed in the nuclei of the undifferentiated tumor cells (D). (E and H) Immunostaining of NPC tumor (E) and C18 nude mice tumor (H)
with preimmune polyclonal rabbit anti-DNase serum. (F and G) Immunostaining of paraffin-wax-embedded NPC tumors by immunoperoxidase
technique using immune polyclonal rabbit anti-DNase serum; 3-T1 tumor (F) and 7-T3 tumor (G). Brown color represents a positive signal. (I and
J) Immunostaining of paraffin-wax-embedded C18 nude mice tumor by immunoperoxidase technique using immune polyclonal rabbit anti-DNase
serum. The arrow in J indicates the foci positive to EBV-DNase.
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the cytoplasm (Fig. 5G). No such staining was obtained ence of 300 mM KCl is probably of viral origin, since
cellular DNase activities were almost completely inhib-on EBV-negative lymphoma used as negative control
(data not shown). EBV-DNase expression was also inves- ited at this salt concentration (Ooka et al., 1984). As sum-
marized in Table 1, of the primary biopsy samples, fivetigated by immunohistochemistry on the C18 tumor
where human infiltrating lymphocytes have been elimi- of eight gave equal or greater activity with 300 mM NaCl
than with 10 mM NaCl. This is an unusual phenomenonnated. The rabbit anti-DNase serum gave intense spe-
cific staining but with smaller foci than in fresh NPC in comparison with the enzyme activity found in lymph-
oblastoid cells, such as EBV-carrying Raji, P3HR-1, orbiopsies (Fig. 5I and 5J). Such positive staining was never
observed with the rabbit preimmune serum (Fig. 5H). B95-8 cells, or in comparison with the purified viral
DNase of the P3HR-1 strain (Clough, 1979, 1980; Ooka
et al., 1984). The EBV-DNase induced in these B cellsDISCUSSION
has generally residual activity at 300 mM KCl. The activa-
tion of enzyme activity by high salt concentrations wasThe presence of an active viral DNase was demon-
strated by several approaches in epithelial NPC tumors. also confirmed on the viral activity eluted on DNA cellu-
lose from 3-T1, which functions much better at 300 mMThe evidence was supported by (1) the presence of
DNase transcript and EBV-DNase polypeptide revealed than at 10 mM NaCl (Fig. 3). Moreover, the viral enzyme
present in the 7-T3 NPC biopsy had a particular capacityby a specific rabbit polyclonal antibody, (2) the presence
of activity resistant to high salt concentration and neutral- of degrading DNA in a high salt concentration, since the
enzyme reaction was carried out in the presence of 300ized by both a rabbit polyclonal serum and a human NPC
serum, and (3) the presence of positive staining in NPC mM KCl plus 260 mM NaCl (from 0.8 M NaCl). The elution
pattern on the DNA column from the 7-T3 sample wasbiopsies with anti-EBV DNase antibody.
From immunoblot data, of the transplantable tumors quite different from 3-T1: (i) a high salt-dependent activity
in 7-T3 biopsy was eluted at 0.5 – 0.8 M NaCl instead of(C15, C17, C18), only C18 showed a high expression of
DNase. Recent work showed that EBV-DNase was not 0.2 – 0.3 M NaCl and (ii) the absence of typical cellular
enzyme activity was observed in the expected fractionfound in C15 tumor using a mouse serum against B95-
8 EBV-DNase (Baylis et al., 1991). However, a faint band (0.1 M NaCl). The latter phenomenon is likely due to a
small amount of cellular enzyme present in this tumor.of DNase was identified in C15 and C17 tumors with our
polyclonal antibody in this study. This discrepancy may Concerning the high salt-dependent activity eluted at
0.5 – 0.8 M NaCl, there are no explanations for this phe-reflect some differences in the antibodies used in these
experiments. Recently we observed significant differ- nomenon; however, we noticed that there was a signifi-
cant activity eluted from the DNA column at 0.8 M NaClences in the antigenic make-up of B95-8- and P3HR-1-
encoded DNase: an antibody made from B95-8 DNase in P3HR-1 cellular extract, as in the 7-T3 biopsy case.
Since the enzymes were not well purified (only a one-could not recognize DNase derived from P3HR-1, while
a polyclonal antibody from P3HR-1 DNase showed equal step purification by a batch method), the unusual elution
pattern obtained from the 7-T3 tumor may be due to theactivity to the DNases made from both virus strains (Mid-
deldorp et al., 1995). The antibody produced from P3HR- presence of a complex of the EBV-DNase with other viral
or cellular proteins, particularly in this tumor. Among the1 DNase may be more reactive than that of B95-8.
Interestingly, only the patient donor of C18, in contrast NPC biopsy samples, only this biopsy contained three
distinct major polypeptides (around 52 – 55 kDa) recog-to those of C15 and C17, had a high titer of EA and VCA
antibodies (Busson et al., 1988). In the C18 tumor, the nized by anti-EBV DNase antibody. We, however, do not
know whether the particular elution pattern observed in1.8-kb DNase mRNA could be easily identified by North-
ern blot using a sense riboprobe, while the same tran- 7-T3 is related to the presence of multipolypeptides. In
any case, the DNase activities from both 3-T1 and 7-T3,script was not detectable by the same method in fresh
NPC biopsies as well as C15 and C17 tumors. This diffi- which were activated by high salt, are likely of viral origin,
since their activities were neutralized by anti-EBV-DNaseculty, however, was overcome by the RT-PCR method
permitting the detection of its transcript in both the NPC antibody. These observations indicate that the EBV-
DNase present in NPC biopsy differs from those of BLbiopsies and nude mice tumors. Our data confirmed the
results obtained by Hitt et al. (1989) in which a transcript cells with regard to the activation of its activity by high
salt. Because of the limited size of tumor fragment avail-was localized on the BGLF5 ORF in the C15 tumor. Simi-
lar difficulties concerning the detection of BZLF1 or LMP1 able, DNase was not well purified. Further characteriza-
tion of DNase activity present in NPC tumors will beRNA by Northern blot in NPC tumors were previously
reported (Cochet et al., 1993; Sbih-Lammali et al., 1996), necessary using more pure enzyme.
The data from the immunoblots and enzyme activityindicating that the translational activity in the tumors is
probably more efficient or more stable than the transcrip- assays (Table 1 and Fig. 2) did not show a good correla-
tion: the immunoblot signal from biopsy 2-T1 was almosttional activity.
DNase activity detected in NPC biopsies in the pres- as strong as that from P3HR1 cells (Fig. 2), yet it gave a
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